Login / Signup

Serum indicators in functional high-risk multiple myeloma patients undertaking proteasome inhibitors therapy: a retrospective study.

Linquan ZhanDai YuanXueling GeMei DingJianhong WangXiangxiang ZhouXin Wang
Published in: Hematology (Amsterdam, Netherlands) (2024)
Therefore, in the PIs era, transplantations are still effective therapies for transplant-eligible MM patients.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • multiple myeloma
  • prognostic factors
  • patient reported outcomes